Other
Other liabilities
Amgen Other liabilities increased by 1.3% to -$75.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.8%, from -$78.00M to -$75.00M. Over 3 years (FY 2021 to FY 2025), Other liabilities shows a downward trend with a 50.6% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Fluctuations reflect changes in operational accruals and deferred income, which can impact short-term cash flow availability.
Detailed definition
The net change in miscellaneous short-term and long-term liabilities not classified as accounts payable or debt. These o...
Peer comparison
Commonly reported in cash flow statements; varies based on specific business model accruals.
Metric ID:
other_increase_decrease_in_other_operating_liabilitiesHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $402.00M | $99.00M | -$267.00M | -$396.00M | $440.00M | $419.00M | -$645.00M | -$78.00M | -$44.00M | -$28.00M | -$72.00M | -$56.00M | -$39.00M | -$78.00M | $0.00 | -$10.00M | -$76.00M | -$75.00M |
| QoQ Change | — | -75.4% | -369.7% | -48.3% | +211.1% | -4.8% | -253.9% | +87.9% | +43.6% | +36.4% | -157.1% | +22.2% | +30.4% | -100.0% | +100.0% | — | -660.0% | +1.3% |
| YoY Change | — | — | — | — | +9.5% | +323.2% | -141.6% | +80.3% | -110.0% | -106.7% | +88.8% | +28.2% | -39.3% | -39.3% | — | +74.4% | — | +3.8% |
Range-$645.00M – $440.00M
CAGR-32.6%
Avg YoY Growth+14.3%
Median YoY Growth+6.6%
Other liabilities at Other Companies
Frequently Asked Questions
- What is Amgen's other liabilities?
- Amgen (AMGN) reported other liabilities of -$75.00M in Q1 2026.
- How has Amgen's other liabilities changed year-over-year?
- Amgen's other liabilities increased by 3.8% year-over-year, from -$78.00M to -$75.00M.
- What is the long-term trend for Amgen's other liabilities?
- Over 3 years (2021 to 2025), Amgen's other liabilities has grown at a 50.6% compound annual growth rate (CAGR), from -$48.00M to -$164.00M.
- What does other liabilities mean?
- The change in various non-debt operational liabilities that do not fall under standard accounts payable.